Syros Pharmaceuticals Net Income 2015-2021 | SYRS

Syros Pharmaceuticals net income from 2015 to 2021. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Syros Pharmaceuticals Annual Net Income
(Millions of US $)
2020 $-84
2019 $-75
2018 $-62
2017 $-54
2016 $-51
2015 $-35
2014 $-16
Syros Pharmaceuticals Quarterly Net Income
(Millions of US $)
2021-09-30 $-26
2021-06-30 $-22
2021-03-31 $-14
2020-12-31 $-30
2020-09-30 $-19
2020-06-30 $-17
2020-03-31 $-17
2019-12-31 $-20
2019-09-30 $-20
2019-06-30 $-19
2019-03-31 $-16
2018-12-31 $-18
2018-09-30 $-16
2018-06-30 $-14
2018-03-31 $-14
2017-12-31 $-15
2017-09-30 $-14
2017-06-30 $-13
2017-03-31 $-12
2016-12-31 $-11
2016-09-30 $-14
2016-06-30 $-14
2016-03-31 $-12
2015-12-31
2015-09-30 $-10
2015-06-30 $-7
2014-12-31
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.167B $0.015B
Syros Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on treatments for cancer and immune-mediated diseases as well as building a pipeline of gene control medicines. The company's product pipeline includes SY-1425, a selective RARa agonist for genomically defined subsets of patients with relapsed or refractory acute myeloid leukemia and relapsed high-risk myelodysplastic syndrome and SY-1365, a selective CDK7 inhibitor for acute leukemia which is in preclinical stage. Syros Pharmaceuticals, Inc. is based in Cambridge, Massachusetts.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $144.122B 9.11
Bio-Rad Laboratories (BIO.B) United States $18.677B 37.90
QIAGEN (QGEN) Netherlands $11.053B 18.72
Biohaven Pharmaceutical Holding (BHVN) United States $8.002B 0.00
Emergent Biosolutions (EBS) United States $2.809B 10.10
Arcus Biosciences (RCUS) United States $2.516B 0.00
Myovant Sciences (MYOV) United Kingdom $1.432B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.186B 0.00
Zymeworks (ZYME) Canada $0.697B 0.00
Ambrx Biopharma (AMAM) United States $0.230B 0.00
SQZ Biotechnologies (SQZ) United States $0.229B 0.00
Enzo Biochem (ENZ) United States $0.160B 20.69